Established Investigator Award Archives | Melanoma Research Foundation

Chromatin Remodeling Alterations and Consequences for Melanoma Metastasis

by Adam Smartt | Sep 26, 2022 | Established Investigator Award

Noncanonical Autophagy Inhibition as a New Approach to Melanoma Therapy

by Adam Smartt | Sep 26, 2022 | Established Investigator Award

Role of the Gli2 Pathway in Melanoma Immunotherapy Resistance

by Adam Smartt | Sep 26, 2022 | Established Investigator Award

Biomarkers to Predict Melanoma Patient Immunotherapy Outcomes

by Adam Smartt | Sep 26, 2022 | Established Investigator Award

Novel Target for Melanoma Therapeutic Development

by Adam Smartt | Dec 15, 2020 | Established Investigator Award, Featured

Established Investigator Award 2020 Linda Malkas, PhD Beckman Research Institute of the City of Hope

Converting Regulatory into Proinflammatory Anti-Tumor Effector T Cells

by Adam Smartt | Nov 30, 2020 | Established Investigator Award, Featured

Established Investigator Award 2020 Thorsten Mempel, MD, PhD Massachusetts General Hospital

« Older Entries

Upcoming Events

Ocular Melanoma Patient and Caregiver Symposium

Tampa, FL

Friday, March 31, 2023

University of North Carolina Patient Symposium

University of North Carolina & Virtual

Monday, May 1, 2023

Miles for Melanoma DC

Yards Park

Saturday, May 6, 2023

Northwest Melanoma Patient Symposium

Fred Hutchinson Cancer Center & Virtual

Saturday, May 20, 2023

Miles for Melanoma Memphis

Shelby Farms Park

Saturday, June 3, 2023

View All Events

Meta

TOGETHER WE CAN FUND THE FUTURE!

Donate what you can

YOUR GENEROSITY ADVANCES LIFE-SAVING MELANOMA RESEARCH.

THANK YOU!


 

    
Name:
 

 


 
Email:




	

				

				

		

				
			
                 
 
                        
                            Become an Advocate
                        
                        Name*
                            
                            
                                                    
                                                    First
                                                
                            
                                                    
                                                    Middle
                                                
                            
                                                    
                                                    Last
                                                
                            
                                                    
                                                    Suffix
                                                
                        
Title
Professional Suffix
Organization
Email*
                            
                        
Address*    
                    
                         
                                        
                                        Street Address
                                    
                                        
                                        Address Line 2
                                    
                                    
                                    City
                                 
                                        
                                        State
                                      
                                    
                                    ZIP / Postal Code
                                
                    
                
Phone
I identify as*
I am interested in more information about…
                            
          
            
            
            
            
            
            
            
            
            
        
                        
                        
		


				

				            
		
	


    
    
    
    	
	
    PATIENTS & CAREGIVERS▼Newly Diagnosed
Treatment Center Finder
Find Support▼Patient Forum
Patient & Caregiver Meetings
Connect with Others
Survivorship
Bereavement
Financial Assistance
Clinical Trials
Cutaneous Melanoma▼Diagnosis (Cutaneous)
Treatment (Cutaneous)
Resources (Cutaneous)
Ocular Melanoma▼Diagnosis (Ocular)
Treatment (Ocular)
Resources (Ocular)
Mucosal Melanoma▼Diagnosis (Mucosal)
Treatment (Mucosal)
Resources (Mucosal)
Pediatric & AYA Melanoma▼Diagnosis (Pediatric)
Treatment (Pediatric)
Resources (Pediatric)
MELANOMA EDUCATION▼Understand Melanoma▼What Melanoma Looks Like
Facts & Stats
Cutaneous Melanoma
Ocular Melanoma
Mucosal Melanoma
Pediatric & AYA Melanoma
Melanoma Prevention
Melanoma Awareness
Skin of Color & Melanoma
Education Institute
Provider Education
Courses
Patient Meetings
RESEARCH & SCIENCE▼Research Grants▼Research Grant RFPs
Funded Research
Supported Institutions
Scientific Initiatives▼VISION Registry
MRF Breakthrough Consortium
CURE Ocular Melanoma
Pediatric & Mucosal Melanoma
Scientific Meetings
Partnerships
Participate in Science▼Participate in Clinical Trials
Advocate for Legislative Issues
Review Grant Applications
Fundraise
Scientific Leadership
ADVOCATE▼Our Impact
Advocacy Priorities▼Federal Funding
Prevention
Access
Education
Take Action
Advocacy News
Advocacy Events
Global Melanoma Coalition
HOW TO HELP▼Gift Planning
Give
Memorial Giving
Endowment
Volunteer
Corporate Giving
Cause Marketing
Merch Store
EVENTS▼Galas
Miles for Melanoma
Host an Event
Patient Symposium
Advocacy
Scientific Meetings
ABOUT US▼Staff
Board of Directors
Scientific Leadership
News & Press▼SPOTlight Newsletter
Eye on OM Newsletter
Advocacy Newsletter
Programs & Initiatives▼CURE Ocular Melanoma
Pediatric & Mucosal Melanoma
Financials & Annual Reports
Careers
Contact

Chromatin Remodeling Alterations and Consequences for Melanoma Metastasis

Noncanonical Autophagy Inhibition as a New Approach to Melanoma Therapy

Role of the Gli2 Pathway in Melanoma Immunotherapy Resistance

Biomarkers to Predict Melanoma Patient Immunotherapy Outcomes

Novel Target for Melanoma Therapeutic Development

Converting Regulatory into Proinflammatory Anti-Tumor Effector T Cells

Upcoming Events

Recent Comments

Archives

Categories

Meta

Research Grant Opportunities

Stay Updated

Become an Advocate